Table 4. Hematologic Reconstitution Data... | American Society of Hematology

Table 4.

Hematologic Reconstitution Data

Patient No.	Chemotherapy	CD34 × 10⁶ per kg Body Weight	Days Until ANC >500/μL	Days Until
				Platelet Count >20,000/μL
2	HD-Mel	2.3	10	11
3	HD-Mel	2.7	11	11
4	HD-Mel	2.04	12	11
	ICE	4.8	9	11
5	HD-Mel	2.7	9	10
	ICE	3.1	10	12
6	HD-Mel	5.56	11	11
10	ICE^4-151	1.5	11	12
	ICE^4-151	1.5	10	10
12	HD-Mel	3.9	9	10
13^4-150	HD-Mel	3.15	10	10
	ICE	5.19	10	11

Patient No.	Chemotherapy	CD34 × 10⁶ per kg Body Weight	Days Until ANC >500/μL	Days Until
				Platelet Count >20,000/μL
2	HD-Mel	2.3	10	11
3	HD-Mel	2.7	11	11
4	HD-Mel	2.04	12	11
	ICE	4.8	9	11
5	HD-Mel	2.7	9	10
	ICE	3.1	10	12
6	HD-Mel	5.56	11	11
10	ICE^4-151	1.5	11	12
	ICE^4-151	1.5	10	10
12	HD-Mel	3.9	9	10
13^4-150	HD-Mel	3.15	10	10
	ICE	5.19	10	11

Abbreviation: HD, high-dose.

In addition to CD34-selected cells, unmanipulated PBPC were retransfused.

A modified ICE regimen was used: 10 g/m² ifosfamide, 1,200 mg/m² etoposide, and 1,200 mg/m² carboplatin.